Kenai Therapeutics

United States
Wonewoc, Wisconsin, United States

Company profile

Kenai Therapeutics company profile

Kenai Therapeutics focuses on developing therapies for neurodegenerative movement disorders. The company provides off-the-shelf neuron replacement medicines as effective disease-modifying treatments for neurological disorders, providing doctors with techniques to treat diseases like Parkinson's.

Business identity

Phone number
815-505-6466
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2022-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
4
Total equity funding
$85M
Last funding
Grant / $8M / 2026-01-05
Last equity funding
Series A / $82M
Investors
6
Lead investors
5
Founders
3
Articles
24

Founders and investors

Founders

Carter CliffHoward J. FederoffJeffrey Kordower

Lead investors

Alaska Permanent FundCalifornia Institute for Regenerative MedicineCure VenturesSaisei VenturesThe Column Group

Investors

Alaska Permanent FundCalifornia Institute for Regenerative MedicineCure VenturesSaisei VenturesThe Column Group